41
edits
Changes
Jump to navigation
Jump to search
Keratoconjunctivitis Sicca (view source)
Revision as of 10:25, 21 February 2014
, 10:25, 21 February 2014no edit summary
'''Cyclosporine''' is believed to help manage KCS by reducing immune-mediated destruction of the gland and by stimulating '''tear production''' by binding with '''prolactin receptors'''. Once treatment is started, tear production should be tested after a month. If there is a good response the dose may be tapered.
'''Cyclosporine''' is believed to help manage KCS by reducing immune-mediated destruction of the gland and by stimulating '''tear production''' by binding with '''prolactin receptors'''. Once treatment is started, tear production should be tested after a month. If there is a good response the dose may be tapered.
====Tear Substitutes===
====Tear Substitutes====
A range of human tear substitute products may be used in dogs. Individuals react differently to different formulations so authors recommend trialling different preparations to see which gives the best clinical response.
A range of human tear substitute products may be used in dogs. Individuals react differently to different formulations so authors recommend trialling different preparations to see which gives the best clinical response.